Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

biopharmadive.com

BioPharma Dive - Latest News

Get the latest updates from BioPharma Dive - Latest News directly as they happen.

Follow now 125 followers

Latest posts

Last updated about 4 hours ago

Cancer drugmaker LaNova to sell to China’s Sino Biopharm

about 5 hours ago

Sino Biopharmaceuticals plans to pay up to nearly $951 million to acquire...

Hengrui, Kailera say dual-acting obesity shot succeeds in China study

about 5 hours ago

The results position Hengrui to seek approval of the Zepbound-like drug in...

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug

about 5 hours ago

NHS England has agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile...

AstraZeneca blood pressure drug succeeds in late-stage trial

1 day ago

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could...

Private equity firms back PCI Pharma in strategic bet on drug production

1 day ago

The CDMO, which has been owned by different private investors over the...

FDA rejects Ultragenyx gene therapy over manufacturing concerns

1 day ago

While the complete response letter derails a near-term clearance, one analyst described...

Takeda to seek approval of new kind of narcolepsy drug after study data

1 day ago

Positive late-stage study results position the company to file for clearance of...

From data to decisions: How pharma can move faster without sacrificing trust

1 day ago

Pharma's speed advantage depends on trust. Is your data foundation strong enough?

Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update

4 days ago

Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile...

With Verona deal, Merck wagers on strength of lung drug’s patents

4 days ago

The main patent for Ohtuvayre, the COPD drug at the heart of...

FDA turns back Capricor’s Duchenne cell therapy

4 days ago

The company said it was “surprised” by the decision, which followed the...

Soleno sales of new Prader-Willi drug rise faster than expected

5 days ago

Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares...